Clinical characteristics and prognostic factors of rheumatoid arthritis-associated lymphoproliferative disorders in the era of biologic and targeted synthetic disease-modifying antirheumatic drugs: a multicenter retrospective study

This multicenter retrospective study evaluated the clinicopathological features, prognostic factors, and evolution of rheumatoid arthritis-associated lymphoproliferative disorders (RA-LPD) treatment in the biologic and targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) era. We analyzed 217 patients diagnosed at eight Japanese institutions. Spontaneous regression was observed in 30.4% of patients with RA-LPD. Extranodal involvement was significantly more common in diffuse large B-cell lymphoma (DLBCL)-type, whereas Epstein-Barr virus positivity was higher in classical Hodgkin lymphoma (CHL)-type. DLBCL-type demonstrated superior progression-free survival (PFS) compared to CHL-type, while overall survival (OS) was comparable. Histological subtype was the sole independent predictor of PFS. Multivariate analysis identified low hemoglobin levels, elevated lactate dehydrogenase levels, and poor performance status as independent adverse prognostic factors for OS. Post-LPD diagnosis, methotrexate was discontinued in most patients, followed by an increased use of b/tsDMARDs. Transitioning to b/tsDMARDs represents a feasible strategy to balance RA control and oncological safety.

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-11-13
DOI
https://doi.org/10.1080/10428194.2026.2758496
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical characteristics and prognostic factors of rheumatoid arthritis-associated lymphoproliferative disorders in the era of biologic and targeted synthetic disease-modifying antirheumatic drugs: a multicenter retrospective study

Naruko Suzuki, Norie Nakatani, Takahiro Nishiyama, Shingo Kurahashi et al.
Leukemia & lymphoma/Leukemia and lymphoma
Lymphoma Diagnosis and Treatment
article

Clinical characteristics and prognostic factors of rheumatoid arthritis-associated lymphoproliferative disorders in the era of biologic and targeted synthetic disease-modifying antirheumatic drugs: a multicenter retrospective study

Naruko Suzuki, Norie Nakatani, Takahiro Nishiyama, Shingo Kurahashi, Satomi Sahashi, Kotaro Miyao, Shoichiro Okazaki, Naoto Imoto, Masashi Sawa, Yusuke Yamaga, Rintaro Minami, Hitoshi Kiyoi, Yasuhiko Harada, Tetsuya Nishida, Katsuya Furukawa, Kazuyuki Shimada
article en

Abstract

This multicenter retrospective study evaluated the clinicopathological features, prognostic factors, and evolution of rheumatoid arthritis-associated lymphoproliferative disorders (RA-LPD) treatment in the biologic and targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) era. We analyzed 217 patients diagnosed at eight Japanese institutions. Spontaneous regression was observed in 30.4% of patients with RA-LPD. Extranodal involvement was significantly more common in diffuse large B-cell lymphoma (DLBCL)-type, whereas Epstein-Barr virus positivity was higher in classical Hodgkin lymphoma (CHL)-type. DLBCL-type demonstrated superior progression-free survival (PFS) compared to CHL-type, while overall survival (OS) was comparable. Histological subtype was the sole independent predictor of PFS. Multivariate analysis identified low hemoglobin levels, elevated lactate dehydrogenase levels, and poor performance status as independent adverse prognostic factors for OS. Post-LPD diagnosis, methotrexate was discontinued in most patients, followed by an increased use of b/tsDMARDs. Transitioning to b/tsDMARDs represents a feasible strategy to balance RA control and oncological safety.

Leukemia & lymphoma/Leukemia and lymphoma
Konan Kosei Hospital (JP), Gifu Prefectural Tajimi Hospital (JP), Ichinomiya Municipal City Hospital (JP), Japanese Red Cross Nagoya Daiichi Hospital (JP), Toyota Kosei Hospital (JP), Anjo Kosei Hospital (JP), Toyohashi Municipal Hospital (JP), Nagoya University (JP)
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon